Nanocare Technologies, Inc. (New York) was co-founded in 2010 by Dr. Milo Lopes (San Carlos, Brazil) and David Katona (New York).
Dr. Lopes made the discovery of A14 in Brazil. He carried out several preliminary studies that support preclinical development. Further preclinical development of A14 will be done in the US.
Patents are owned by the US company. The initial International Patent Application was filed in July 2008, and published in August 2009. A second US Patent Application was filed in March 2012.
We are pleased to work with Cooley LLP for both our intellectual property and corporate legal services.